Skip to main content
. 2022 Nov 29;12:1033993. doi: 10.3389/fonc.2022.1033993

Figure 1.

Figure 1

Pediatric hyperleukocytosis pathway. (A) Pathway overview. (B) Patient risk stratification. (C) Empiric leukemia-directed therapy. (D) Definitions and additional management.